Persia Fabio A, Rinaldini Estefanía, Carrión Adriana, Hapon María Belén, Gamarra-Luques Carlos
Instituto de Medicina y Biología Experimental de Cuyo - CONICET, Mendoza, Argentina.
Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina.
Medicina (B Aires). 2017;77(4):283-290.
Higher plants have provided various natural derived drugs used currently in western medicine. Tessaria absinthioides (Hook. & Arn.) DC, Asteraceae, is a native plant from South-America with reported ethnopharmacological and culinary uses. Despite recent scientific reports about plants properties, there is not a well conducted research about its anticancer and potential toxic effects. The current work demonstrates the plant aqueous extract composition; the in vitro induced cytotoxicity, and explores, in vivo, its oral toxicity and antitumoral effects. Composition of aqueous extract was determined by phytochemical reactions. Cytotoxicity was tested in tumoral (Hela, Gli-37, HCT-116 and MCF-7) and non-tumoral (HBL-100) cells, using MTT assay. Oral toxicity and the antitumor activity against colorectal carcinoma were studied in rodents. The chemical analysis revealed the presence of flavonoids, carbohydrates, sterols, terpenes and tannins. Cytotoxicity towards tumoral cells was observed (CV50: 3.0 to 14.8 υg/ml); while in non-tumoral cells, extracts evidenced a selective reduced toxicity (CV50: 29.5 υg/ml). Oral administration of the extract does not induce acute nor dose-repeated toxicity at doses up to 2000 mg/kg and 1000 mg/kg/day, respectively. The antitumoral effect was confirmed by a significant increase in a median survival from 24 weeks (non-treated) to 30 weeks (T. absinthioides treated). The present data indicate that T. absinthioides extract exhibits cytotoxicity against cancer cell lines, with no-toxic effects and significant antitumoral effects in colorectal cancer when is orally administrated. In conclusion, T. absinthioides possesses selective cytotoxicity and antitumoral activities, making its plant derivatives products promising for cancer research and treatment.
高等植物提供了目前在西医中使用的各种天然衍生药物。菊科植物苦艾叶特萨里亚(Tessaria absinthioides (Hook. & Arn.) DC)是一种原产于南美洲的植物,有关于其民族药理学和烹饪用途的报道。尽管最近有关于该植物特性的科学报告,但尚未对其抗癌和潜在毒性作用进行充分的研究。当前的研究展示了该植物水提取物的成分;体外诱导的细胞毒性,并在体内探索了其口服毒性和抗肿瘤作用。通过植物化学反应确定水提取物的成分。使用MTT法在肿瘤细胞(Hela、Gli - 37、HCT - 116和MCF - 7)和非肿瘤细胞(HBL - 100)中测试细胞毒性。在啮齿动物中研究口服毒性和对结直肠癌的抗肿瘤活性。化学分析显示存在黄酮类化合物、碳水化合物、甾醇、萜类和单宁。观察到对肿瘤细胞的细胞毒性(半数致死浓度:3.0至14.8微克/毫升);而在非肿瘤细胞中,提取物显示出选择性降低的毒性(半数致死浓度:29.5微克/毫升)。分别以高达2000毫克/千克和1000毫克/千克/天的剂量口服提取物不会诱导急性毒性或剂量重复性毒性。通过中位生存期从24周(未治疗)显著增加到30周(苦艾叶特萨里亚治疗)证实了抗肿瘤作用。目前的数据表明,苦艾叶特萨里亚提取物对癌细胞系具有细胞毒性,口服给药时对结直肠癌无毒性作用且具有显著的抗肿瘤作用。总之,苦艾叶特萨里亚具有选择性细胞毒性和抗肿瘤活性,使其植物衍生产品在癌症研究和治疗方面具有前景。